Hedge Fund and Insider Trading News: John Griffin, Jim Simons, Seth Klarman, Daniel Kamensky, Engaged Capital, JPMorgan Chase & Co. (JPM), Columbia Sportswear Company (COLM), and More

Page 2 of 2

Friday 4/17 Insider Buying Report: JPM, ECOR (Nasdaq.com)
On Thursday, JPMorgan Chase’s Director, Stephen B. Burke, made a $6.6M purchase of JPM, buying 75,000 shares at a cost of $87.99 each. So far Burke is in the green, up about 5.5% on their buy based on today’s trading high of $92.80. JPMorgan Chase is trading up about 5.2% on the day Friday. This buy marks the first one filed by Burke in the past twelve months. And on Tuesday, Director James L. L. Tullis purchased $1.5M worth of ElectroCore, purchasing 1,764,705 shares at a cost of $0.85 each. Before this latest buy, Tullis purchased ECOR on 2 other occasions during the past year, for a total investment of $85,212 at an average of $1.62 per share. ElectroCore is trading up about 19.4% on the day Friday. Tullis was up about 29.4% on the purchase at the high point of today’s trading session, with ECOR trading as high as $1.10 at last check today.

A Major Shareholder at Columbia Sportswear (NASDAQ: COLM) is Selling Shares (Analyst Ratings)
Today, a Major Shareholder at Columbia Sportswear (COLM), Sarah Bany, sold shares of COLM for $1.01M. In addition to Sarah Bany, 2 other COLM executives reported Sell trades in the last month. Based on Columbia Sportswear’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $955 million and quarterly net profit of $114 million.

Regeneron Pharmaceuticals Inc (REGN) EVP General Counsel and Secret Joseph J Larosa Sold $1.2 million of Shares (Guru Focus)
EVP General Counsel and Secret of Regeneron Pharmaceuticals Inc., Joseph J Larosa, sold 2,262 shares of REGN on 04/15/2020 at an average price of $518.21 a share. The total sale was $1.2 million. Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

SEC Awards Over $27 Million to Whistleblower (HedgeCo.net)
(HedgeCo.Net) The Securities and Exchange Commission today announced an award of more than $27 million to a whistleblower who alerted the agency to misconduct occurring, in part, overseas. After providing the tip to the Commission, the whistleblower provided critical investigative leads that advanced the investigation and saved significant Commission resources. “This award marks several milestones for the program,” said Jane Norberg, Chief of the SEC’s Office of the Whistleblower. “This is the largest whistleblower award announced by the Commission this year, and the sixth largest award overall since the inception of the program. This award also brings the total amount awarded to whistleblowers by the SEC over the $400 million mark.”

Page 2 of 2